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La sindrome fibromialgica (FM) è una comune condizione di dolore cronico che interessa almeno il 2% della popo-
lazione. Il dolore cronico diffuso è l’elemento caratterizzante la FM, ma i pazienti possono riferire una varietà di al-
tri sintomi, compresi disturbi del sonno, astenia, sindrome da colon irritabile, cefalea, e disturbi del tono dell’umore.
L’eziologia della FM non è completamente conosciuta e la sindrome viene influenzata da una varietà di fattori quali
stress, malattie mediche e una molteplicità di condizioni dolorose. Stabilire la diagnosi può essere difficile a causa
della natura multiforme della sindrome e della sovrapposizione con altre sindromi dolorose croniche. Un’ipotesi uni-
ficatrice è che la FM risulti dalla sensibilizzazione del sistema nervoso centrale; questo nuovo concetto potrebbe giu-
stificare la varietà di caratteristiche cliniche della sindrome. I sintomi della FM possono essere muscolo scheletrici,
non-muscoloscheletrici o una combinazioni di entrambi e molti pazienti sperimentano un insieme di sintomi o condi-
zioni cliniche. I criteri classificativi ACR si focalizzano solamente sul dolore e non considerano altri sintomi impor-
tanti, ma tre sintomi-chiave, dolore, astenia e disturbi del sonno sono presenti praticamente in ogni paziente affetto
da FM. Parecchi altri disturbi associati comprendenti i sistemi circolatorio, nervoso, digestivo, e genito-urinatio so-
no probabilmentre parte della cosiddetta sindrome da sensibilizzazione centrale. Una minoranza dei pazienti (30-40%)
ha un significativo disturbo psicologico. I disturbi psichiatrici più comunemente descritti sono i disturbi del tono
dell’umore, ma le patologie psichiatriche non costituiscono un fattore necessario nella eziopatogenesi della FM.
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INTRODUCTION
Fibromyalgia (FM) is currently classified aschronic widespread pain with widespread al-
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lodynia/hyperalgesia to pressure pain and is cate-
gorized among the large group of soft-tissue pain
syndromes. FM remains an elusive condition of
unknown etiology in which patients report not on-
ly chronic widespread pain but also a variety of
other complaints, so that it is one of several rela-
tively common overlapping syndromes character-
ized by otherwise unexplained chronic pain and fa-
tigue (1, 2).
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The cardinal features are chronic widespread pain
in the presence of multiple tender points through-
out the body on physical examination.
FM, as defined by the American College of
Rheumatology (ACR) 1990 definition for clinical
trials, is a chronic widespread pain condition with
characteristic tender points on physical examina-
tion, often associated with a constellation of symp-
toms such as fatigue, sleep disturbance, headache,
irritable bowel syndrome, and mood disorders. The
ACR defined 2 major compulsory criteria for clas-
sifying FM in adults. The first criterion is a histo-
ry of widespread pain for at least 3 months. The
second criterion requires patient report of tender-
ness in at least 11 of 18 defined tender points when
digitally palpated with about 4 kg per unit area of
force (3). 
Diagnosis is on the contrary made by a combina-
tion of patient history, physical examination, labo-
ratory evaluations, and exclusion of other causes
for symptoms attributed to FM. 
It has also been noted that the ACR classification
criteria focus only on pain and disregard other im-
portant symptoms of FM, including fatigue, cog-
nitive disturbance, sleep disturbance, and psycho-
logical distress, and that focusing strictly on pain
may fail to capture the “essence” of this syndrome
(4). Three key features pain, fatigue and sleep dis-
turbance are present in virtually every patient with
FM (5) even if the hallmark symptom that differ-
entiates FM from most other medical conditions is
the pronounced tenderness to even mildest palpa-
tion or physical touch, i.e. allodynia (6, 7).
A recent study provided some evidence of the se-
riousness of improper diagnosis, criticizing the dis-
turbing diagnostic error rate (66%) (8). With regard
to this, the principal author of the 1990 ACR Cri-
teria recently published an editorial article entitled
“Stop using the ACR Criteria in the Clinic” (9).
In a very recent study, in order to develop a new
definition of FM based on symptoms and without
tender points, the authors concluded that the key
symptoms are chronic widespread pain, non-
restorative sleep and subjective disabilities, im-
plying that FM is more than just a pain disorder
(10).
In the late ’80s, Yunus proposed that preliminary
clinical criteria for FM should include some his-
torical features besides the tender point count, a
description of pain as “hurt all over,” anxiety and
stress, non restorative sleep, fatigue, irritable bow-
el symptoms, and pain referred by patients in sev-
en sites (11).
In 1992 a consensus document (the Copenhagen
declaration) identified FM is part of a wider syn-
drome involving headaches, bruxism, irritable bow-
el, irritable bladder, sleep disorders, dysmenorrhea,
depression and anxiety disorders, cold sensitivity,
Raynaud’s phenomena, restless legs, atypical pat-
terns of numbness and tingling, complaints of
weakness, exercise intolerance, cognitive dysfunc-
tion, autonomic nervous system or neuroendocrine
dysregulation (12).
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Figure 1 - Central Sensitivity Syndrome and its members with over-
lapping features. From Yunus MB.Psychological aspects of fi-
bromyalgia syndrome: a component of the dysfunctional spectrum
syndrome. Baillieres Clin Rheumatol. 1994; 8(4): 811-37. In Rachlin
ES, Rachlin IS. Myofascial Pain and Fibromyalgia, Trigger Point Man-
agement. 2nd ed. St. Louis: Mosby, 2002 (adapted).
Table I - Full OMERACT 8 group responses in percentages (13).
Domain A B C
Pain 94 3 3
Fatigue 86 13 1
Patient Global 81 12 7
Sleep 64 26 10
Multidimensional function 60 28 12
HRQOL 52 34 14
Tenderness 50 27 24
Depression 44 34 21
Treatment side effects 40 34 26
Anxiety 22 43 35
Dyscognition 21 42 37
Stiffness 13 35
52
A: essential for core set for all clinical studie. B: necessary but not mandatory for
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OMERACT 8 workshop on FM in 2006, of which
the principal objective was to work towards con-
sensus on core domains for assessment in FM stud-
ies, identified key domains of pain, fatigue, sleep
disturbance, multidimensional function, quality of
life, mood disorders, and cognitive dysfunction.
An additional domain highlighted by patients was
stiffness (13) (Table I). At last we cannot ignore the
evolving idea of central sensitivity syndrome
(CSS), which is based on neuroendocrine aberra-
tions interacting with psychosocial factors. CSS
becomes an important new concept that embraces
the biopsychosocial model of disease as a useful
paradigm and an appropriate terminology for FM
and related conditions (14, 15) (Fig. 1).
THE SYMPTOMS
The most common and characteristic symptoms of
FM are generalized pain, stiffness, fatigue, and
poor sleep. Other symptoms are a swollen feeling
in soft tissue and paresthesia. Several associated ill-
nesses, more common in FM patients than in nor-
mal population (as well as in those with other
chronic pain conditions) have been well described
(16).
MUSCULOSKELETAL SYMPTOMS
Pain
As mentioned, the defining symptom of FM re-
mains widespread chronic pain that lasts at least
three months, usually present in all four limbs, as
well as the upper or lower back. About two thirds
of the patients state that they “hurt all over”; this
symptom has been found to be useful in differen-
tiating FM from other conditions (11).
Pain may be described as any combination of burn-
ing, searing, tingling, shooting, stabbing, deep
aching, sharp and feeling bruised all over (17).
Some authors, using an adapted McGill Pain Ques-
tionnaire, found that pain in FM had a greater spa-
tial distribution and involved a greater number of
pain descriptors compared to other pain syndromes
(18). 
Common sites of pain are low back, neck, shoul-
der region, arms, hands, knees, hips, thighs, legs,
feet (19), and anterior chest (20). However, pain is
usually generalized and in “non-anatomical” dis-
tribution or regional; it does not follow any definite
structural or nerve root distributions, it is perceived
as originating in the muscle or deep in bones (17),
although in a subgroup of patients it is predomi-
nantly articular (21).
Characteristics of FM pain include allodynia, hy-
peralgesia, persistent pain, summation effects, hy-
perpatia in the skin and tenderness on examina-
tion.
Pain is often aggravated, like stiffness, by cold or
humid weather, anxiety or stress, overuse or inac-
tivity, poor sleep (19, 22) and noise (20). The worst
times for an FM patient are in the morning, the lat-
ter half of the afternoon, and evening (23).
Myalgia and muscle dysfunctions
Pain often includes widespread myalgia that is not
necessarily confined to the tender points, and with
characteristics that vary widely even in an individ-
ual patient. It can also appear as low back pain,
sometimes simulating sciatica; in this case there
may be a concomitant myofascial pain syndrome
(piriformis, gluteus).
Approximately 40% of FM patients reported leg
cramps in comparison to 2% of controls (24).
Myalgia can be accompanied by muscle weakness
and fasciculations with or without general weak-
ness. Muscle function is globally impaired (most of
all aerobic processes) (25) and strength is general-
ly reduced in the hand and quadriceps, in particu-
lar (26).
Many studies failed to demonstrate typical and spe-
cific muscle abnormalities. Bioptic studies (27-29)
revealed only non-specific signs of muscle pathol-
ogy without pathognomonic flags of FM. Needle
electromyography found minor and, again, non-
specific changes looking for pathological evidence
of motor unit recruitment (no loss of motor units
and no fiber degeneration) (30). Multichannel sur-
face electromyography seems to be of some inter-
est, giving original information about acute alter-
ation of motor unit recruitment strategies and
chronic modification of muscle fiber type distribu-
tion, number or size (31, 32). Muscle alteration
that is clinically expressed as fatigue could be the
peripheral aspect of a central alteration of the sen-
sory-motor interaction. 
Muscles in a patient with FM probably undergo a
pathologic remodelling related to an altered
suprasegmental control (33). Because of this, their
function is incorrect and ineffective. 
However, these results are not strictly related to fi-
bromyalgic muscle; they have also been recorded,
for example, in healthy, deconditioned elderly pop-
ulations (34).
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Stiffness
In FM patients, stiffness, typically, is not only ar-
ticular but also generalized (global stiffness) and is
common; but unlike in rheumatoid arthritis, it is
worse upon awakening and in the evening. The in-
cidence of morning stiffness lasting more than fif-
teen minutes has been reported in as many as 83%
of patients (35).
Morning stiffness does not correlate with severity
of FM (19), but it does correlate with pain (36).
Swollen feeling in tissue
Swelling of the hands and feet is often present in
FM and is sometimes accompanied by numbness
and tingling. Generalized swelling may be present
as the result of inactivity as well.
In many patients, the sensation of swelling is pre-
sent (22), even if no objective joint swelling is pre-
sent on physical examination. In some patients, the
skin overlying a muscle with known myofascial
pain syndrome can exhibit the characteristic or-
ange peel skin; however, trophic edema does not
“pit” upon digital pressure in these cases.
NON-MUSCULOSKELETAL SYMPTOMS
Fatigue
Fatigue is quite common in FM; it is generally
worse in the morning and patients often awaken
feeling more exhausted than when they went to
bed. Moderate or severe fatigue occurs in about
75% to 90% of patients (35, 36). Patients will typ-
ically describe their fatigue using the expression,
“I’m always tired.” Other descriptors for fatigue
include exhaustion, tiredness, lack of energy, and
sometimes, a global feeling of general weakness. 
Fatigue in these patients seems to be unexpected or
inappropriate with a delayed reactivity following
physical exertion (next day or even later). After ex-
ercise FM patients can feel worse rather than bet-
ter. Normal physical or intellectual exertion may
take an inordinate amount of time to regain the pre-
exertion level of function and competence. Fatigue
may be generated by many different mechanisms.
Arousal fatigue is a typical cause of fatigue in FM;
it results from an inadequate quantity or quality of
sleep or from some medications. Muscular fatigue
is commonly seen in FM, and motivational fatigue
is usually associated with depression, which is pre-
sent in about 30% or more of FM patients (17). Fa-
tigue is also associated with pain severity and func-
tional disabilities (37).
Sleep dysfunction
Non restorative sleep is common in FM. About
75% of patients describe sleep disturbances that
may include early, middle or late insomnia; hyper-
somnia; frequent awakening; light sleep with ir-
regular diurnal rest; or reversed or chaotic sleep
rhythms. Poor sleep may aggravate pain and may
also contribute to disturbed sleep. There is a rela-
tionship, in fact, between poor sleep and pain, and
sleep disturbances are important in the genesis of
tender points (37, 38).
Loss of deeper phases of sleep (stages three and
four) is characteristic of FM and leads to the loss
of restorative feelings on awakening.
Polysomnographic studies have shown that, com-
pared to controls, FM patients experience a reduced
portion of deep sleep, REM sleep, and total sleep
time, a greater number of awakenings and a sig-
nificant pattern indicating the intrusion of alpha
waves on delta rhythm (39).
Some researchers have suggested that alpha intru-
sion is an intrinsic characteristic of non-REM sleep
in FM patients (40-42). Others, however, do not
agree because this phenomenon may be observed
in normal individuals and in patients with other
chronic pain syndromes, such as rheumatoid arthri-
tis and chronic fatigue syndrome (41, 43). Still oth-
er researchers have demonstrated a poor presence
of alpha waves intrusion during deep sleep in FM
patients (44, 45).
From these varied studies, a reasonable conclusion
is that fragmented sleep is an important factor for
the physiopathology of FM symptoms; and al-
though an excess of alpha intrusion is not specific
for FM, it may be considered a sensitive marker for
non-restorative sleep nevertheless.
Restless legs syndrome or periodic limb movement
disorder may also contribute to sleep disturbances.
Restless legs syndrome has been reported in ap-
proximately 30% of FM patients compared to 2%
of controls (24). Periodic limb movement disorder
is another common sleep disturbance that affects
about 30% of patients over the age of 50. It is of-
ten independent of the presence of FM and is char-
acterized by transient episodes (0.5 to 5 seconds)
of partial bending of the ankles, knees, or hips (46).
This disorder is common, but is not as significant
in FM patients.
Sleep apnea syndrome and other breathing condi-
tions, like periodic breathing during sleep, might be
observed in FM patients. Sleep apnea syndrome is
characterized by recurring episodes of upper
breathing apparatus (mouth and nose) obstruction
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during sleep with significant ipopnea or apnea (47).
About 2% of women and 44% of men with FM are
affected by sleep apnea syndrome (48). In spite of
this, apneas are unlikely culprits for FM symptoms
(49).
Paresthesia
Paresthesia has been shown to appear in as many
as 84% of FM patients (50) and occurs predomi-
nantly in the extremities. In some patients these
symptoms can be quite severe but without sensory
deficits on physical examination. This symptom is
described as tingling, “pins and needles,” or numb-
ness. Paresthesia may have a radiating quality that
mimics a neurologic disorder but without radicu-
lar distribution. Electromyographic and nerve con-
duction velocity studies are normal in these pa-
tients (50).
ADDITIONAL CLINICAL SYMPTOMS
The clinical presentation of FM may vary some-
what, and the additional symptoms, though not re-
quired for ACR criteria, are still clinically impor-
tant (Table II).
Neurologic manifestations
FM patients often report symptoms that are neuro-
logical in nature. Muscle dysfunction often mani-
fests as a hypertonic or hypotonic state, an abnor-
mal twitch response, cramps, weakness and fasci-
culation. Headaches, temporomandibular joint dis-
order, perceptual disturbances, spatial and tempo-
ral instability and sensory overload phenomena of-
ten occur. In particular, the patient may be hyper-
sensitive to light, sound, noise, speed, odours and
other mixed sensory modalities. Perceptual distur-
bances may include dizziness, numbness, tinnitus,
nausea or shooting pain (17).
Neurocognitive manifestations
Neurocognitive disturbances are usually present in
FM patients. These include impaired concentration
and short-term memory consolidation, reduced per-
formance speed, inability to multi-task, dis-
tractibility and cognitive overload. Complaints of
cognitive “fog” (fibro-fog) or simple confusion,
linguistic performance impairment, dyslexia when
fatigued, and difficulty with writing, reading, math-
ematics, word retrieval and speaking are especial-
ly common. It is easy for patients to lose track of
things and to forget many things (17).
FM patients have cognitive function that is worse
than that in age-matched controls (51) and similar
to that in adults 20 years older with respect to long-
term memory and working memory (i.e. the
amount of information a person can store and
process simultaneously) (52).
FM patients are able to perform at a similar level
as healthy controls, but this is only due to more ex-
tensive neural activation in frontal and parietal
brain regions (53). This supports the hypothesis
that FM patients show an aging effect that requires
increased use of cognitive resources to maintain
comparable levels of performance as their same-
aged peers. 
The finding of an acceleration of age-related brain
changes has been supported by the observation that
FM patients had significantly less total gray mat-
ter volume and 3.3 times greater age-associated de-
crease in gray matter than healthy controls. The
longer the individuals had had fibromyalgia, the
greater the gray matter loss, with each year of fi-
bromyalgia being equivalent to 9.5 times the loss
in normal aging (54). 
This is probably due to the mechanism of neuro-
toxicity (neuronal apoptosis).
Table II - Symptoms in Fibromyalgia Syndrome Based on Several Lar-
ge Series.
Symptoms Mean*
Musculoskeletal
Pain at multiple sites 100
Stiffness 78
“Hurt all over” 64
Swollen feeling in tissue 47
Nonmusculoskeletal
General fatigue 86
Morning fatigue 78
Poor sleep 65
Paresthesia 54
Associated syndrome
Headaches 53
Dysmenorrhea 43
Irritable bowel syndrome 40
Restless legs syndrome 31
Sicca syndrome 15
Raynaud’s phenomenon 13
Female urethral syndrome 12
*Mean values derived from percentage figures reported in several studies. In Ra-
chlin ES e Rachlin IS Myofascial pain and fibromyalgia: trigger point management
(30). Modified from Yunus MB, Masi AT: Fibromyalgia, restless legs syndrome,
periodic limb movement disorder and psychogenic pain. In McCart DJ Jr, Koop-
man WJ (eds): Arthritis and Allied Conditions: A Textbook of Rheumatology, 12th
ed. Philadelphia, Lea & Febiger, 1993, pp 1383-1405.
Autonomic and neuroendocrine manifestations
These manifestations indicate a general loss of in-
ternal homeostasis and adaptation. They include
cardiac arrhythmias, hypotension, dizziness, sense
of lightheadedness, vertigo, vasomotor instability,
sicca syndrome, temperature instability, heat or
cold intolerance, respiratory disturbances, intesti-
nal and bladder motility disturbances, dysmenor-
rhea, loss of adaptability and tolerance for stress,
emotional flattening, and reactive depression (17).
Associated symptoms and conditions and central
sensitivity syndrome
Chronic headaches, irritable bowel, irritable blad-
der and female urethral syndromes, primary dys-
menorrhea, restless legs syndrome, and sicca syn-
drome have been often described in FM, more com-
mon than in pain-free normal controls (3). But sev-
eral other similar syndromes, including FM, are
now considered to form a spectrum of illnesses
with central sensitivity, described previously as
CSS (15) (Table III).
Psychiatric disorders and psychological factors
Psychological factors are an important determi-
nant of any form of pain including chronic pain,
irrespective of the cause, and FM is no exception.
Psychological distress perpetuates pain, and
chronic pain may cause psychological distur-
bance.
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Table III - Symptoms that may be present, not included as part of the criteria for diagnosis (17).
Musculoskeletal system
Generalized stiffness
Muscle cramps
Chest pressure and pain
TMJ dysfunction
Nervous system
Persistent fatigue
Lack of endurance
Migraines or new onset headaches
Sensory
Hypersensitivity to pain
Hyperresponsiveness to noxious stimulus
Perceptual and dimensional distortions
Feeling of burning or swelling
Sensory overload phenomena
Loss of cognitive map
Dyspnea
Cognitive
Difficulties processing information
Slowness in cognitive processing
Concentration problems
Difficulties with word retrieval
Confusion and word mix-ups
Short-term memory difficulties
Motor and balance
Muscle weakness and paralysis
Poor balance, ataxia and tandem gait
Clumsiness and tendency to drop things
Difficulty in tandem gait
Atypical numbness or tingling
Neuroendocrine system
Marked weight change
Heat/cold intolerance
Neuropsychological
Mood swing, anxiety
Reactive depression
Visual and auditory disturbances
Visual changes or eye pain
Double, blurred and wavy vision
Dry or itchy eyes
Photophobia
Tinnitus-buzzing or ringing in ears
Hyperacusis and interference from background noise
Sleep disturbances
Sleep disorder, hyper or insomnia
Non-refreshing sleep
Circulatory system
Neurally-mediated hypotension
Fainting or vertigo
Palpitations and tachycardia
Fluid retention
Bruising
Digestive system
Lump in throat
Nausea
Heart burn
Abdominal pain
Irritable bowel syndrome
Urinary system
Irritable bladder
Overactive bladder
Reproductive syndrome
Dysmenorrhea
Pre-menstrual syndrome or irregular cycles
Loss of sexual libido or impotence
Anorgasmia
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A minority subgroup of patients (30-40%) has a
significant psychological disturbance (55).
Several studies provide evidence that psychiatric
disorders occur at significantly higher rates in sub-
jects with FM compared with other pain patients or
healthy controls. Other studies contend that the fre-
quency of such distress is similar to that in other
chronic disease, such as rheumatoid arthritis (55).
Studies examining psychiatric comorbidity in com-
munity samples of subjects with FM found elevat-
ed levels of psychopathology (56, 57), although
psychiatric illness is not a necessary factor in the
etiopathogenesis of FM.
Psychiatric disorders most commonly described
are mood disorders.
Current major depression has been detected in 14-
36% of patients with FM (58, 59) compared to 6.6
% of healthy subjects in a community sample (60).
Family history studies indicate a higher prevalence
of mood disorders in first degree relatives of pa-
tients with FM compared to first degree relatives of
patients with rheumatoid arthritis and healthy con-
trols (61, 62).
Subjects with FM report childhood traumatic ex-
periences more frequently than medically ill or
healthy controls; and they report a high prevalence
of emotional neglect or abuse (48%) and physical
maltreatment (23%) as well (63).
Job-related stress or or physical stressors may act
as precipitating factors, but the impact of these
stressors may only be realized if they have strong
personal significance. An etiopathogenetic link be-
tween FM and life stress is also suggested by the
comorbid occurrence of post-traumatic stress dis-
order.
Post-traumatic stress disorder symptoms were
founded in 56% of patients with FM (64).
Research on personality traits in FM has yielded in-
consistent results, but no personality disorders have
been associated with FM (65).
Despite all of this, cognitive styles are increasing-
ly being recognized as important factors in the ex-
perience of pain. For example, catastrophizing,
which is characterized by pessimistic beliefs about
oneself, others, and the future and by defining pain
as awful and unbearable, is a common cognitive
style that is known to modulate pain reports and
pain-related disability. It seems to play a substan-
tial role in the development of pain chronicity and
in the experience of chronic pain and pain-related
disability. It is an independent factor that is only
partially associated with depression.
Catastrophizers hardly shift their attention away
from painful or threatening stimuli, and they at-
tach more threator harm to non-painful stimuli than
is warranted (66).
THE SIGNS
The most significant finding related to FM is the
presence of multiple tender points (3). Tender
points are best elicited by manual palpation, specif-
ically by digital pressure using an approximate to-
tal force of four Kg. A small subgroup of patients
is diffusely tender all over. It is necessary to un-
derline that the tender point never aches sponta-
neously.
Other physical signs, though not necessary for di-
agnosis, are skinfold tenderness, which is assessed
by pinching a fold of skin and subcutaneous tis-
sue on tender point sites, cutaneous hyperaemia
at the tender point site after examination, and
reticular discoloration (livedo reticularis) in the
extremities.
Negative findings are the absence of joint swelling,
a normal range of joint motion and muscle strength,
and normal sensory function and reflexes (56).
CONCLUSION
FM is a chronic pain condition in which patients
report not only widespread pain but also a variety
of other complaints. The cardinal features are
chronic widespread pain in the presence of multi-
ple tender points throughout the body on physical
examination. The ACR 1990 definition for clinical
trials proposed compulsory criteria for classifying
FM in adults and was not intended to be used for
clinical diagnosis.
On the contrary, diagnosis is made by a combina-
tion of patient history, physical examination, labo-
ratory evaluations, and exclusion of other causes
for symptoms attributable to FM.
Three key features - pain, fatigue and sleep distur-
bance - are present in virtually every patient with
FM. The hallmark symptom that differentiates FM
from most other medical conditions is allodynia to
even the mildest palpation or physical touch. The
tender point, which never aches spontaneously, is
the only cardinal sign, and it can be elicited by
manual palpation via digital pressure.
FM symptoms can be summarized in muscu-
loskeletal, non-musculoskeletal, and additional
clinical symptoms. 
Associated symptoms and conditions must be con-
sidered in patient’s evaluation because several as-
sociated illnesses are more common in FM patients
than in the normal population.
The evolving idea of CSS, which is based on neu-
roendocrine aberrations interacting with psy-
chosocial factors, will be an important new concept
to consider in the daily diagnosis of FM and relat-
ed conditions.
The Wolfe editorial entitled “Stop using the ACR
Criteria in the Clinic” is a great article that will en-
courage physicians to obtain complete knowledge
of all common and uncommon FM symptoms to
minimize improper diagnosis.
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SUMMARY
Fibromyalgia syndrome (FM) is a common chronic pain condition that affects at least 2% of the adult population. Chron-
ic widespread pain is the defining feature of FM, but patients may also exhibit a range of other symptoms, including
sleep disturbance, fatigue, irritable bowel syndrome, headaches, and mood disorders. The etiology of FM is not com-
pletely understood and the syndrome is influenced by factors such as stress, medical illness, and a variety of pain con-
ditions. Establishing diagnosis may be difficult because of the multifaceted nature of the syndrome and overlap with
other chronically painful conditions. A unifying hypothesis is that FM results from sensitization of the central nervous
system; this new concept could justify the variety of characteristics of the syndrome. FM symptoms can be muscu-
loskeletal, non-musculoskeletal, or a combination of both; and many patients will also experience a host of associat-
ed symptoms or conditions. The ACR classification criteria focus only on pain and disregard other important symp-
toms; but three key features, pain, fatigue and sleep disturbance, are present in virtually every patient with FM. Sev-
eral other associated syndromes, including circulatory, nervous, digestive, urinary and reproductive systems are prob-
ably a part of the so called central sensitivity or sensitization syndrome. A minority subgroup of patients (30-40%) has
a significant psychological disturbance. Psychological factors are an important determinant of any type of pain, and
psychological comorbidity is frequent in FM. Psychiatric disorders most commonly described are mood disorders, but
psychiatric illness is not a necessary factor in the etiopathogenesis of FM.
Key words - Fibromyalgia, symptoms, sleep disorders, restless leg syndrome, chronic pain, fatigue.
Parole chiave - Fibromialgia, sintomi, disturbi del sonno, syndrome delle gambe senza riposo, dolore cronico, fatica.
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